Surgical research in urology and renal trasplantation

Group leader

Francisco Javier Burgos Revilla

fjavier.burgos(ELIMINAR)@salud.madrid.org

Tlf.: +34 91 3368760

Collaborating Staff

  • Victoria Gómez Dos Santos
  • Rafael Rodríguez-Patrón Rodríguez
  • Sara Álvarez Rodríguez
  • Víctor Díez Nicolás
  • Vital Hevia Palacios
  • Ana Belén Serrano Romero
  • José López Menéndez
  • Guillermo Fernández Conejo
  • José Daniel Subiela Henriquez
  • Alberto del Cristo Artiles Medina
  • Silvia Garcia Barreras
  • Pablo Gajate Borau
  • Javier Molina Cerrillo
  • Javier Sáenz Medina
  • Irene de la Parra Sánchez
  • César Mínguez Ojeda
Imagen equipo

Group leader

Francisco Javier Burgos Revilla

fjavier.burgos(ELIMINAR)@salud.madrid.org

Tlf.: +34 91 3368760

Collaborating Staff

  • Victoria Gómez Dos Santos
  • Rafael Rodríguez-Patrón Rodríguez
  • Sara Álvarez Rodríguez
  • Víctor Díez Nicolás
  • Vital Hevia Palacios
  • Ana Belén Serrano Romero
  • José López Menéndez
  • Guillermo Fernández Conejo
  • José Daniel Subiela Henriquez
  • Alberto del Cristo Artiles Medina
  • Silvia Garcia Barreras
  • Pablo Gajate Borau
  • Javier Molina Cerrillo
  • Javier Sáenz Medina
  • Irene de la Parra Sánchez
  • César Mínguez Ojeda

Strategic objectives

  • To advance the pathophysiological understanding of ischemia-reperfusion injury in the context of kidney transplantation through translational research from the experimental to the clinical setting.
  • To identify biomarkers that predict graft viability and function after kidney transplantation.
  • To advance the development of models for pharmacological modulation of ischemia-reperfusion injury during kidney preservation in perfusion devices.
  • To evaluate the diagnostic yield and therapeutic efficacy of new diagnostic and treatment techniques for prostate cancer: MRI fusion biopsy and ultrasound using guided navigation systems, focal prostate cancer ablation techniques, and intraoperative neurostimulation of neurovascular bundles in prostate surgery.
  • To actively participate in multicenter studies evaluating new molecules for the treatment of prostate cancer.
  • To actively participate in multicenter studies and cooperative groups for the study and treatment of functional and oncological bladder pathology.
  • To search for biomarkers that predict treatment response and disease recurrence, as well as to molecularly characterize the neoplasia and tumor microenvironment in renal and urothelial cancer.

Research lines

  • Kidney transplantation and preservation in experimental and clinical settings.
  • Prostate cancer: diagnostic and therapeutic innovation.
  • Diagnostic and therapeutic innovation in bladder pathology.
  • Diagnostic and therapeutic innovation in renal and urothelial tumors.

Location

Urology Service


6th floor left
Ramón y Cajal University Hospital
+34 91 336 87 60

Keywords

kidney transplant, kidney preservation, biomarkers, prostate cancer, prostate fusion biopsy, focal therapy, neuronavigation, renal tumor with vascular invasion, urothelial tumor